Nanomedicine News

RSS
Midatech Secures Swissmedic Approval to Begin First-in-Human Clinical Study of Gold Nanoparticles

Midatech Secures Swissmedic Approval to Begin First-in-Human Clinical Study of Gold Nanoparticles

Novel Nanoparticle Gelatin-Based Drug Delivery System to Treat Blood Cots

Novel Nanoparticle Gelatin-Based Drug Delivery System to Treat Blood Cots

Visualization of Nanoparticles Destroying Cancer Cells

Visualization of Nanoparticles Destroying Cancer Cells

COIN Announce Nano+Bio Executive Roundtable Event

Iroko to Present Findings for Nano-Formulations of Pain Drugs at ACR Meeting

Iroko to Present Findings for Nano-Formulations of Pain Drugs at ACR Meeting

Researchers Design Nanoreactors to Aid in Drug Manufacture

Researchers Design Nanoreactors to Aid in Drug Manufacture

Researchers Discover Nanocomposite Probe to Study Neurological Disorders

Researchers Discover Nanocomposite Probe to Study Neurological Disorders

EuroNanoMed to Fund Eight Nanomedicine Research Projects

EuroNanoMed to Fund Eight Nanomedicine Research Projects

NanoSmart Pharmaceuticals and Children's Hospital, Los Angeles Inks Research Partnership

NanoSmart Pharmaceuticals and Children's Hospital, Los Angeles Inks Research Partnership

Sub-Nanometre Cages Capture and Identify Molecules

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.